Previous K2 Spice/synthetic marijuana coverage in The Washington Post

In remarking Sunday on coverage of the synthetic marijuana products in The New York Times, I totally missed that a more detailed article appeared the day before in The Washington Post.

With contributions from Aaron C. Davis, the article by writer Michael W. Savage provided an insight into Spice use in Adams Morgan and around the District. The second page of the online article goes into much more detail than the NYT article by addressing the pros and cons of state approaches to outlaw the compounds and products.

Savage also included commentary by Marilyn Huestis, chief of chemistry and drug metabolism at the National Institute on Drug Abuse (NIDA), and focused in on a problem we discussed Sunday, namely, that the content of active components in the synthetic products and dosing with the pure compound(s) can vary wildly and account for reports of safe use vs. those of intense anxiety, cardiac disturbances, and seizures.

Savage quotes Dr. Huestis:

"These different, synthetic compounds are up to 100 times more potent than THC and have not been tested on humans," she said. "When people take it, they don't know how much they're taking or what it is they're taking."

It's a really nice overview and it won't take you terribly long to read it.

As more states move toward regulating JWH-018, related compounds, and incense products that contain one or more of the compounds, we will be seeing more of these kinds of articles in the legacy media.

By the way, if you are looking for more science writing, check out Carl Zimmer's fantastic article, How Microbes Defend and Define Us, in today's NYT Science Times section on the microbes that live in our bodies and how "fecal transplants" have proven effective in treating infectious diseases - I kid you not.

More like this

The news of a new antiviral comes at a Press Conference. That could either mean a blockbuster breakthrough or an unwarranted device to get attention for some otherwise decent but not blockbuster science.
The US National Cancer Institute (NCI) has long had programs to make available to researchers any variety of compounds, natural and synthetic. These offerings are administered by the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD).
Iodine week continues with IPBC, or 3-iodo-2-propynyl-N-butylcarbamate, a fungicide:
One of the strengths of science is its systematic approach to getting reliable information about the world by comparing outcomes of experiments where one parameter is varied while the others are held constant.

excellent information, and today we have to be updated and informed about everything to control our children and teach them that these herbs are a great thing but medical ..